MedTrace Logo

Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis

NCT02658344 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-06-05

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Knee Osteoarthritis.

Conditions

Interventions

BIOLOGICAL

JOINTSTEM

Jointstem (Autologous Adipose Tissue derived MSCs 1x10\^8cells/3ml), 1 time injection

DRUG

Saline solution

Saline solution (Sodium chloride 9mg/ml), 1 time injection

Sponsors & Collaborators

  • R-Bio

    lead INDUSTRY

Principal Investigators

  • KANGIL KIM, M.D., Ph.D · KyungHee University Gangdong Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-11-30
Completion
2016-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02658344 on ClinicalTrials.gov